TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Activity

770 hedge funds and large institutions have $24.9B invested in Teva Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 222 increasing their positions, 324 reducing their positions, and 71 closing their positions.

Holders
770
Holders Change
+43
Holders Change %
+5.91%
% of All Funds
22.25%
Holding in Top 10
58
Holding in Top 10 Change
+26
Holding in Top 10 Change %
+81.25%
% of All Funds
1.68%
New
119
Increased
222
Reduced
324
Closed
71
Calls
$1.28B
Puts
$754M
Net Calls
+$529M
Net Calls Change
+$336M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.43B
2
Franklin Resources
2
Franklin Resources
California
$2.6B
3
HCM
3
Highfields Capital Management
Massachusetts
$317M
4
Invesco
4
Invesco
Georgia
$773M
5
PHS
5
PFM Health Sciences
California
$181M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.71B
2
Capital Research Global Investors
2
Capital Research Global Investors
California
$2.29B
3
MIP
3
Mondrian Investment Partners
United Kingdom
$932M
4
BTS
4
BB&T Securities
Virginia
$5.66M
5
U
5
UBS
Switzerland
$118M
Name Market Value Shares Shares
Change 		Shares
Change %
Franklin Resources
1
Franklin Resources
California
$2.6B 49,273,356 +6,179,870 +14%
Capital Research Global Investors
2
Capital Research Global Investors
California
$2.29B 43,387,300 -5,045,000 -10%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$1.71B 32,364,031 -12,935,262 -29%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.43B 27,013,912 +17,601,258 +187%
MIP
5
Mondrian Investment Partners
United Kingdom
$932M 17,630,178 -4,749,322 -21%
Invesco
6
Invesco
Georgia
$773M 14,621,995 +4,378,244 +43%
Allianz Asset Management
7
Allianz Asset Management
Germany
$719M 13,598,793 -2,522,791 -16%
Barrow, Hanley, Mewhinney & Strauss
8
Barrow, Hanley, Mewhinney & Strauss
Texas
$705M 13,335,767 +1,192,204 +10%
PC
9
PointState Capital
New York
$673M 12,736,500 +3,291,100 +35%
SFM
10
Soros Fund Management
New York
$545M 10,310,041 +994,041 +11%
Macquarie Group
11
Macquarie Group
Australia
$463M 8,764,301 -1,488,238 -15%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$441M 8,341,476 -336,824 -4%
Norges Bank
13
Norges Bank
Norway
$408M 7,720,988 – –
NIMC
14
NWQ Investment Management Company
California
$333M 6,294,655 +302,295 +5%
WRF
15
Waddell & Reed Financial
Kansas
$319M 6,041,102 -109,968 -2%
HCM
16
Highfields Capital Management
Massachusetts
$317M 6,000,000 +6,000,000 New
Millennium Management
17
Millennium Management
New York
$274M 5,193,193 +2,326,853 +81%
Lazard Asset Management
18
Lazard Asset Management
New York
$264M 4,994,641 -369,884 -7%
Westfield Capital Management
19
Westfield Capital Management
Massachusetts
$260M 4,912,363 -261,676 -5%
MAA
20
Managed Account Advisors
New Jersey
$238M 4,497,580 +596,121 +15%
RFC
21
Russell Frank Company
Washington
$234M 4,731,779 +366,469 +8%
Schroder Investment Management Group
22
Schroder Investment Management Group
United Kingdom
$213M 4,026,863 -524,913 -12%
Jennison Associates
23
Jennison Associates
New York
$197M 3,728,290 +2,699,462 +262%
ClearBridge Investments
24
ClearBridge Investments
New York
$189M 3,577,681 -9,249 -0.3%
JPMorgan Chase & Co
25
JPMorgan Chase & Co
New York
$184M 3,491,072 +222,880 +7%
1
2 3 4 5